Literature DB >> 3000590

A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption.

H Austin, E Delzell, S Grufferman, R Levine, A S Morrison, P D Stolley, P Cole.   

Abstract

A case-control study was undertaken to evaluate the roles of the hepatitis B virus (HBV), cigarette smoking, and alcohol use in the etiology of hepatocellular carcinoma (HCC). A major purpose of the study was to evaluate the effect of cigarette smoking on HCC among hepatitis B surface antigen (HBsAg)-negative persons, since it had been suggested that the relative effect of cigarette smoking on HCC was higher among HBsAg-negative persons than among HBsAg-positive persons. Eighty-six cases and 161 hospital controls were included in the study. This study confirmed the strong relationship between the HBV and HCC. Twelve of 67 cases and none of 63 controls were chronically infected with HBV as evidenced by serum HBsAg. The study also found a moderately strong relationship between alcohol use and HCC. The results of the present study do not support the hypothesis that cigarette smoking is a risk factor for HCC. Among all subjects, the relative rate of HCC for cigarette smokers compared with nonsmokers after adjustment for alcohol consumption was 1.0 with 95% confidence limits, 0.5 to 1.8. Among HBsAg-negative subjects, the relative rate was 1.1 with 95% confidence limits, 0.5 to 2.4. There was also no consistent dose-response relationship between quantity smoked and HCC in this study.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3000590

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

2.  At-risk drinking in an HMO primary care sample: prevalence and health policy implications.

Authors:  M F Fleming; L B Manwell; K L Barry; K Johnson
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

3.  Cigarette smoking and liver cancer among US veterans.

Authors:  A W Hsing; J K McLaughlin; Z Hrubec; W J Blot; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1990-11       Impact factor: 2.506

Review 4.  Risk factors for hepatocellular carcinoma in India.

Authors:  Premashis Kar
Journal:  J Clin Exp Hepatol       Date:  2014-04-13

5.  Hepatocellular carcinoma and the underlying mechanisms.

Authors:  A A Oyagbemi; O I Azeez; A B Saba
Journal:  Afr Health Sci       Date:  2010-03       Impact factor: 0.927

6.  Prospective study of the association of alcohol with cancer of the upper aerodigestive tract and other sites.

Authors:  I Kato; A M Nomura; G N Stemmermann; P H Chyou
Journal:  Cancer Causes Control       Date:  1992-03       Impact factor: 2.506

7.  Increased morbidity odds ratio of primary liver cancer and cirrhosis of the liver among vinyl chloride monomer workers.

Authors:  C L Du; J D Wang
Journal:  Occup Environ Med       Date:  1998-08       Impact factor: 4.402

Review 8.  Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses.

Authors:  R Naccarato; F Farinati
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

9.  Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.

Authors:  D Y Chien; Q L Choo; A Tabrizi; C Kuo; J McFarland; K Berger; C Lee; J R Shuster; T Nguyen; D L Moyer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  A strong negative association between alcohol consumption and the risk of hepatocellular carcinoma in cirrhotic patients. A case-control study.

Authors:  S Aricó; G Corrao; P Torchio; G Galatola; M Tabone; M Valenti; F Di Orio
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.